Synapse

← The Lancet Regional Health - Europe

Papers in The Lancet Regional Health - Europe

Page 11 · newest first

  1. Digital solutions for migrant and refugee health: a framework for analysis and actionThe Lancet Regional Health - Europe · 2024
  2. A framework for resilient and sustainable health systems in the European RegionThe Lancet Regional Health - Europe · 2024
  3. Lessons learned from the Eastern Europe and central Asia region on the elimination of HIV vertical transmission: insights from United Nations Children’s fundThe Lancet Regional Health - Europe · 2024
  4. Changes in life satisfaction, self-esteem, and self-rated health before, during, and after becoming a young carer in the UK: a longitudinal, propensity score analysisThe Lancet Regional Health - Europe · 2024
  5. Survival and quality of life after first-time diagnosis of brain metastases: a multicenter, prospective, observational studyThe Lancet Regional Health - Europe · 2024
  6. Occurrence, mortality, and economic burden of brain disorders in Denmark, 2015–2021: a population-based cohort studyThe Lancet Regional Health - Europe · 2024
  7. Immuno-metabolic depression: from concept to implementationThe Lancet Regional Health - Europe · 2024
  8. Incidence, case fatality, and functional outcome of intracerebral haemorrhage, according to age, sex, and country income level: a systematic review and meta-analysisThe Lancet Regional Health - Europe · 2024
  9. Efficacy of repeated immunoadsorption in patients with post-COVID myalgic encephalomyelitis/chronic fatigue syndrome and elevated β2-adrenergic receptor autoantibodies: a prospective cohort studyThe Lancet Regional Health - Europe · 2024
  10. Internal mammary node irradiation in 4541 node-positive breast cancer patients treated with newer systemic therapies and 3D-based radiotherapy (DBCG IMN2): a prospective, nationwide, population-based cohort studyThe Lancet Regional Health - Europe · 2024
  11. Advancing paediatric allergy care: key findings from the largest trial of house dust mite sublingual immunotherapy-tablets in childrenThe Lancet Regional Health - Europe · 2024
  12. Impact and cost-effectiveness of scaling up HCV testing and treatment strategies for achieving HCV elimination among people who inject drugs in England: a mathematical modelling studyThe Lancet Regional Health - Europe · 2024
  13. Impact of surrogates for insulin resistance on mortality and life expectancy in primary care: a nationwide cross-sectional study with registry linkage (LIPIDOGRAM2015)The Lancet Regional Health - Europe · 2024
  14. How we count matters – infections are a major cause of death among patients with type 2 diabetesThe Lancet Regional Health - Europe · 2024
  15. Medical research agency: 5 years of reshaping the clinical trials ecosystem in PolandThe Lancet Regional Health - Europe · 2024
  16. Association between cardiometabolic diseases and the risk and progression of motor neuron diseases in Sweden: a population-based case–control studyThe Lancet Regional Health - Europe · 2024
  17. Association between HPV vaccination and cervical screening policy changes and cervical cancer incidence and grade-3 cervical intraepithelial neoplasia incidence in England, 2006–2020: a population-based trends analysisThe Lancet Regional Health - Europe · 2024
  18. Frailty prevalence, invasive treatment frequency, and in-hospital outcome in patients hospitalized for acute coronary syndrome in Germany (2005–2022): a nationwide registry studyThe Lancet Regional Health - Europe · 2024
  19. HBV and HCV testing outcomes among marginalized communities in Italy, 2019–2024: a prospective studyThe Lancet Regional Health - Europe · 2024
  20. Clinical characteristics and serological profiles of Lyme disease in children: a 15-year retrospective cohort study in SwitzerlandThe Lancet Regional Health - Europe · 2024
  21. Scurvy incidence trend among children hospitalised in France, 2015–2023: a population-based interrupted time-series analysisThe Lancet Regional Health - Europe · 2024
  22. Development and validation of artificial intelligence models for early detection of postoperative infections (PERISCOPE): a multicentre study using electronic health record dataThe Lancet Regional Health - Europe · 2024
  23. Short-term effect of temperature and precipitation on the incidence of West Nile Neuroinvasive Disease in Europe: a multi-country case-crossover analysisThe Lancet Regional Health - Europe · 2024
  24. Physiological versus time based cord clamping in very preterm infants (ABC3): a parallel-group, multicentre, randomised, controlled superiority trialThe Lancet Regional Health - Europe · 2024
  25. Benefit from dose-dense adjuvant chemotherapy for breast cancer: subgroup analyses from the randomised phase 3 PANTHER trialThe Lancet Regional Health - Europe · 2024
  26. Hypertension and orthostatic hypotension in the elderly: a challenging balanceThe Lancet Regional Health - Europe · 2024
  27. Leveraging digital medication adherence technologies to enhance sustainability of European health systems: ENABLE’s key recommendationsThe Lancet Regional Health - Europe · 2024
  28. Impact of disease-modifying therapies on pregnancy outcomes in multiple sclerosis: a prospective cohort study from the German multiple sclerosis and pregnancy registryThe Lancet Regional Health - Europe · 2024
  29. Benefits and harms associated with the use of AI-related algorithmic decision-making systems by healthcare professionals: a systematic reviewThe Lancet Regional Health - Europe · 2024
  30. Clinical utility of the Fibrosis-4 index for predicting mortality in patients with heart failure with or without metabolic dysfunction-associated steatotic liver disease: a prospective cohort studyThe Lancet Regional Health - Europe · 2024
  31. Bipolar disorders: an update on critical aspectsThe Lancet Regional Health - Europe · 2024
  32. Comparative efficacy and acceptability of psychosocial interventions for PTSD, depression, and anxiety in asylum seekers, refugees, and other migrant populations: a systematic review and network meta-analysis of randomised controlled studiesThe Lancet Regional Health - Europe · 2024
  33. Contribution of infection to mortality in people with type 2 diabetes: a population-based cohort study using electronic recordsThe Lancet Regional Health - Europe · 2024
  34. Efficacy and safety of SQ house dust mite sublingual immunotherapy-tablet (12 SQ-HDM) in children with allergic rhinitis/rhinoconjunctivitis with or without asthma (MT-12): a randomised, double-blind, placebo-controlled, phase III trialThe Lancet Regional Health - Europe · 2024
  35. The overlooked burden of persistent physical symptoms: a call for action in European healthcareThe Lancet Regional Health - Europe · 2024
  36. WHO's iSupport model for dementia care: why the mode and measures matterThe Lancet Regional Health - Europe · 2024
  37. Evaluating the effects of the World Health Organization's online intervention ‘iSupport’ to reduce depression and distress in dementia carers: a multi-centre six-month randomised controlled trial in the UKThe Lancet Regional Health - Europe · 2024
  38. Wealth and health: the neglected economic determinantThe Lancet Regional Health - Europe · 2024
  39. Humoral and cellular responses to a fifth bivalent SARS-CoV-2 vaccine dose in patients with immune-mediated inflammatory diseases on tumour necrosis factor inhibitors: a prospective cohort studyThe Lancet Regional Health - Europe · 2024
  40. Health system response to war and displacement in Europe requires transformative actions and policiesThe Lancet Regional Health - Europe · 2024
  41. Compromises in determination of Mycoplasma pneumoniae incidenceThe Lancet Regional Health - Europe · 2024
  42. Association between gambling disorder and suicide mortality: a comparative cohort study using Norwegian health registry dataThe Lancet Regional Health - Europe · 2024
  43. Recent achievements and future directions of anti-obesity medicationsThe Lancet Regional Health - Europe · 2024
  44. Wealth and mortality among late-middle-aged individuals in Norway: a nationwide register-based retrospective studyThe Lancet Regional Health - Europe · 2024
  45. Ethnic disparities in lung cancer incidence and differences in diagnostic characteristics: a population-based cohort study in EnglandThe Lancet Regional Health - Europe · 2024
  46. Why are we still in need for novel anti-obesity medications?The Lancet Regional Health - Europe · 2024
  47. Realizing Germany's leadership potential in global health: a gender equity roadmapThe Lancet Regional Health - Europe · 2024
  48. The importance of understanding pelvic inflammatory disease as a polymicrobial infection - authors’ replyThe Lancet Regional Health - Europe · 2024
  49. The importance of understanding pelvic inflammatory disease as a polymicrobial infectionThe Lancet Regional Health - Europe · 2024
  50. Monkeypox clade IIb in France in 2023–2024The Lancet Regional Health - Europe · 2024